Longitudinal anti-SARS-CoV-2 antibody profile and neutralization activity of a COVID-19 patient - 06/08/20
Doi : 10.1016/j.jinf.2020.06.076
Shengxia Yin a, #, Xin Tong a, #, Aijun Huang b, Han Shen b, Yang Li b, Yong Liu c, Chao Wu a, Rui Huang a, ⁎ 
, Yuxin Chen b, ⁎
, Yuxin Chen b, ⁎ a Department of Infectious Diseases, Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, Nanjing, Jiangsu, China
b Department of Laboratory Medicine, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, Jiangsu, China
c Department of Experimental Medicine, Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, Nanjing, Jiangsu, China
⁎Corresponding authors.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Abstract |
We followed–up a mild COVID-19 patient for 91 days and serially monitored his serum antibodies to four SARS-CoV-2 related antigens (NP, RBD, S1 and ECD) and neutralization activities. Our data revealed a profile of serial antibody responses during the progress and a quick decline of neutralization activities after discharge.
Le texte complet de cet article est disponible en PDF.© 2020
Elsevier Ltd. Tous droits réservés.
Vol 81 - N° 3
P. e31-e32 - septembre 2020 Retour au numéro
Article précédent
- Underestimation of co-infections in COVID-19 due to non-discriminatory use of antibiotics
- Chien-Yi Chang, Kok-Gan Chan
- Elevation of ACE2 as a SARS-CoV-2 entry receptor gene expression in Alzheimer's disease
- Key-Hwan Lim, Sumin Yang, Sung-Hyun Kim, Jae-Yeol Joo
Bienvenue sur EM-consulte, la référence des professionnels de santé.